Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06751290 · ClinicalTrials.gov registry record · Phase 4
The Use of Cyproheptadine in Pediatric Feeding Disorders
A Phase 4 study of Avoidant Restrictive Food Intake Disorder and Pediatric Feeding Disorder, Chronic, sponsored by University of Miami.
- Active
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06751290: Active Phase 4 study of Avoidant Restrictive Food Intake Disorder and Pediatric Feeding Disorder, Chronic, sponsored by University of Miami.
NCT06751290 is a Phase 4 study of Avoidant Restrictive Food Intake Disorder and Pediatric Feeding Disorder, Chronic that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 50 participants, below the 4,043-participant average among 5 other Avoidant Restrictive Food Intake Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06751290, a Phase 4 study of Avoidant Restrictive Food Intake Disorder and Pediatric Feeding Disorder, Chronic, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if Cyproheptadine, an appetite stimulant, can improve eating habits in children with Pediatric Feeding Disorders. Pediatric Feeding Disorders is a broad term that describes disorders of eating-related behaviors that causes altered consumption of food and impairs physical or psychosocial health.
Primary Outcome
A composite score will be obtained and scores range from 1-5 with higher scores indicating more behavioral eating.
Conditions Studied
Interventions
- BEHAVIORAL Nutritional Counseling
- DRUG Cyproheptadine
- BEHAVIORAL Behavioral Counseling
Study Locations (1)
Florida
- University of Miami Department of Pediatric Gastroenterology - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-12-30 |
| Est. Completion | 2026-04-30 |
| Phase | Phase 4 |
What the registry record for NCT06751290 still lists
NCT06751290 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 4,043-participant average among 5 other Avoidant Restrictive Food Intake Disorder trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Avoidant Restrictive Food Intake Disorder appearing as the primary indexed condition, and to 3 interventions - of which Nutritional Counseling is the first listed.
NCT06751290 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06751290 about?
NCT06751290 is a clinical study titled "The Use of Cyproheptadine in Pediatric Feeding Disorders". The goal of this clinical trial is to learn if Cyproheptadine, an appetite stimulant, can improve eating habits in children with Pediatric Feeding Disorders. Pediatric Feeding Disorders is a broad term that describes disorders of eating-related behaviors that causes altered consumption of food and i...
What is the current status of trial NCT06751290?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2024-12-30. Estimated completion is 2026-04-30.
What conditions does trial NCT06751290 study?
This clinical trial studies the following conditions: Avoidant Restrictive Food Intake Disorder, Pediatric Feeding Disorder, Chronic.
What interventions are being tested in trial NCT06751290?
The interventions under investigation include: Nutritional Counseling (BEHAVIORAL), Cyproheptadine (DRUG), Behavioral Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06751290?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06751290 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avoidant Restrictive Food Intake Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
CGM in Patients With ED's
COMPLETED
-
Confirming the Efficacy/Mechanism of Family Therapy for Children With Low Weight ARFID
COMPLETED · NA
-
Evaluating Hunger Manipulation During Feeding Intervention
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI